dithionitrobenzoic acid has been researched along with lipoamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, JM; Nelson, DJ; Qu, ZC | 1 |
| Arnér, ES; Berners-Price, SJ; Callus, BA; Cheng, Q; Davies, SM; Filipovska, A; McNamara, E; Miranda-Vizuete, A; Rackham, O; Shearwood, AM; Thyer, R | 1 |
2 other study(ies) available for dithionitrobenzoic acid and lipoamide
| Article | Year |
|---|---|
Cellular disulfide-reducing capacity: an integrated measure of cell redox capacity.
Topics: Cell Line; Disulfides; Dithionitrobenzoic Acid; Endothelial Cells; Glutathione; Humans; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Thioctic Acid | 2006 |
Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Topics: Animals; Antioxidants; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cisplatin; Cytosol; Dithionitrobenzoic Acid; Enzyme Inhibitors; Humans; Mice; Mitochondria; Naphthoquinones; Organogold Compounds; Oxidation-Reduction; Recombinant Proteins; Substrate Specificity; Thioctic Acid; Thioredoxin Reductase 1; Thioredoxin Reductase 2; Thioredoxins | 2011 |